₹-8.00
(Market cap
₹43 Cr
Recently Viewed
Clear AllMarket cap
₹43 Cr
Revenue (TTM)
₹17 Cr
P/E Ratio
--
P/B Ratio
1.1
Div. Yield
2.8 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-1 Cr
ROE
20.7 %
ROCE
23.8 %
Industry P/E
395.23
EV/EBITDA
-60.9
Debt to Equity
0
Book Value
₹118.1
EPS
₹-4.1
Face value
10
Shares outstanding
3,350,500
CFO
₹16.54 Cr
EBITDA
₹21.94 Cr
Net Profit
₹30.80 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
NG
| -15.2 | 9.6 | -5.5 | -18.6 | 18.0 | 23.0 | 4.3 |
|
BSE Healthcare
| 2.6 | 5.0 | 8.0 | 6.4 | 25.0 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
NG
| -19.0 | 8.9 | 101.0 | 29.3 | 48.2 | -25.3 | -19.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
NG
|
127.0 | 42.6 | 16.5 | -1.4 | 6.6 | -3.6 | -- | 1.1 |
| 63.5 | 65.4 | 24.2 | 1.5 | 5.5 | 11 | 44.6 | 5.1 | |
| 705.3 | 36,540.5 | 4,461.2 | 397.5 | 13.4 | 9.1 | 111.7 | 7.9 | |
| 441.6 | 14,003.2 | 1,976.2 | 160.7 | 14.1 | 6.7 | 111.1 | 7.1 | |
| 1,411.7 | 23,668.0 | 2,662.8 | 533.1 | 22.9 | 24.1 | 44.8 | 9.2 | |
| 662.3 | 26,529.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 88.2 | 11.4 | |
| 120.2 | 249.4 | 51.6 | 0.7 | 1.3 | 1.1 | 381.8 | 4.1 | |
| 1,241.9 | 12,598.4 | 1,613.3 | 259.9 | 23.0 | 17.3 | 48.9 | 7.9 | |
| 17.2 | 39.1 | 0.0 | -8.7 | -- | -64.3 | -- | 3.4 | |
| 70.2 | 30.0 | 27.2 | -2.0 | -3.4 | -287.5 | -- | -28.7 |
No Review & Analysis are available.
N G Industries LTD provides various healthcare services in India. The company operates a diagnostic center with daycare and nursing home facilities providing a range of medical services in the fields of pathology, radiology, cardiology,... gastroenterology, infertility, and minimal invasive surgeries, as well as multispecialty clinics. It also offers inpatient and outpatient, as well as pharmacy dispensing services. The company was founded in 1994 and is based in Kolkata, India. Read more
Incorporated
1994
Chairman
Rajesh Goenka
Managing Director
--
Headquarters
Kolkata, West Bengal
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of NG Industries Ltd is ₹127.00 (BSE) as of 28-Apr-2026 IST. NG Industries Ltd has given a return of 17.98% in the last 3 years.
Since, TTM earnings of NG Industries Ltd is negative, P/E ratio is not available.
The P/B ratio of NG Industries Ltd is 1.08 times as on 28-Apr-2026, a 75 discount to its peers’ median range of 4.28 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
7.06
|
1.42
|
|
2024
|
10.41
|
1.45
|
|
2023
|
3.22
|
0.95
|
|
2022
|
7.96
|
0.87
|
|
2021
|
21.72
|
0.89
|
The 52-week high and low of NG Industries Ltd are Rs 180.00 and Rs 114.00 as of 28-Apr-2026.
NG Industries Ltd has a market capitalisation of ₹ 43 Cr as on 28-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in NG Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.